Davion Healthcare Plc (DAVI)
| Market Cap | 34.75M |
| Revenue (ttm) | n/a |
| Net Income | -967,450 |
| EPS | -0.04 |
| Shares Out | 25.00M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 294,135 |
| Open | 1.540 |
| Previous Close | 1.580 |
| Day's Range | 1.320 - 1.560 |
| 52-Week Range | 1.310 - 12.300 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Apr 6, 2027 |
About DAVI
Davion Healthcare Plc, a digital healthcare company, engages in the design, development, and commercialization of non-invasive health monitoring technologies. Its core consumer health portfolio comprises proprietary, home-based monitoring devices designed to support the early identification of potential medical anomalies. The company’s flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. It is also developing a portfolio of pr... [Read more]
News
Davion Healthcare Plc Appoints Vienna Capital Partners to Support US$100 Million Acquisition Financing Strategy
Financial advisory appointment to support planned acquisitions of profitable, revenue-generating businesses during 2027 Financial advisory appointment to support planned acquisitions of profitable, re...
Davion Healthcare PLC Agrees $13.5 Million Acquisition of Profitable US Home Healthcare Business
First in a planned programme of acquisitions to expand Davion's revenues, earnings and healthcare operations First in a planned programme of acquisitions to expand Davion's revenues, earnings and heal...
Davion Healthcare Announces US$25 Million Acquisition of Humaskan Medical Technology IP
Acquisition adds battery-free smart wound dressing and two-minute multi-marker screening test to Davion's growing healthcare portfolio Acquisition adds battery-free smart wound dressing and two-minute...
DAVION HEALTHCARE PLC CONFIRMS EXPECTED NASDAQ TRADING DATE AND ANNOUNCES NEW EXECUTIVE LEADERSHIP AND OPERATING STRUCTURE
Ordinary shares expected to commence trading on Nasdaq Global Market on Thursday 22 October 2026 under ticker "DAVI" Glenn Williams appointed Chief Executive Officer and Jeremy North Chief Operating O...
Davion Healthcare Annual report: Q4 2025
Davion Healthcare has published its Q4 2025 annual report on April 30, 2026.
Davion Healthcare Registration statement: Registration filing
Davion Healthcare filed a registration statement on December 5, 2025, providing details about a securities offering with the SEC.